In that sense, a relatively large number of studies have evaluated the association between p21 rs1801270 (Ser31Arg) polymorphism and the risk of several types of cancers (lung cancer, breast cancer, CC, gastric cancer, etc.), though the results remain inconclusive [23,29–31] due to the complexity of p21 function. The gene discussed is CDKN1A; the disease is breast cancer.